NCT01638546
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01638546
Title Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Johns Hopkins Bayview Medical Center Baltimore Maryland 21224 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
Washington University School of Medicine St Louis Missouri 63110 United States Details
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Sleepy Hollow Sleepy Hollow New York 10591 United States Details
Memorial Sloan Kettering Nassau Uniondale New York 11553 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
VCU Massey Comprehensive Cancer Center Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field